Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-25

Clinical Trial Update: Subcutaneous vs. Intramuscular Testosterone [Phase 4]

View source ↗

Summary

Phase 4 trial comparing subcutaneous versus intramuscular testosterone in men with testosterone deficiency/hypogonadism completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Men's Health Boston | Conditions: Testosterone Deficiency, Hypogonadism, Male | Phase 4 | Status: COMPLETED | Results posted: 2019-09-25